Radiomics and radiogenomics of primary liver cancers.

摘要: Concurrent advancements in imaging and genomic biomarkers have created opportunities to identify non-invasive surrogates of molecular phenotypes. In order develop such radiomics radiogenomics/imaging genomics will be necessary; there has been consistent progress these fields for primary liver cancers. this article we evaluate the current status field specifically with regards hepatocellular carcinoma intrahepatic cholangiocarcinoma, highlighting some up coming results that were presented at annual Radiological Society North America Conference 2017. There are an increasing number studies area a bias towards quantitative feature measurement, which is expected benefit reproducibility findings portends well future development diagnosis, prognosis, treatment response assessment. We review look forward exciting applications anticipated as develops.